{"abstract":"The Food and Drug Administration (FDA, the Agency, or we) is issuing this notice to request that public stakeholders notify FDA of their intent to participate in periodic consultation meetings on reauthorization of the Animal Drug User Fee Act (ADUFA). The statutory authority for ADUFA expires September 30, 2028. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that FDA consult with a range of stakeholders--including patient and consumer advocacy groups, veterinary professionals, and scientific and academic experts--in developing recommendations for the next ADUFA program and hold discussions with these stakeholders at least once every 4 months during FDA's negotiations with the regulated industry. The purpose of this request for notification is to ensure consistent stakeholder representation at the consultation meetings.","action":"Notice; request for notification of participation.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/05/11/2026-09283.html","cfr_references":[],"citation":"91 FR 25576","comment_url":"http://www.regulations.gov/commenton/FDA-2011-N-0656-1315","comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Submit notification of intent to participate in continued periodic stakeholder consultation meetings regarding ADUFA reauthorization by June 1, 2026. These stakeholder meetings are expected to commence in June 2026 and will continue at least once every 4 months during reauthorization negotiations with the regulated industry. See the SUPPLEMENTARY INFORMATION section for further information regarding notification of intent to participate.","disposition_notes":null,"docket_ids":["Docket No. FDA-2011-N-0656"],"dockets":[{"supporting_documents":[{"title":"Summary of Comments Received","document_id":"FDA-2011-N-0656-0037"}],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-05-11","updated_at":"2026-08-13T06:55:55.856-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2011-N-0656-1315","allow_late_comments":false,"id":"FDA-2011-N-0656-1315","comment_end_date":"2027-12-02","regulations_dot_gov_open_for_comment":true}],"supporting_documents_count":1,"id":"FDA-2011-N-0656","title":"Animal Drug User Fee Act; Public Meeting"}],"document_number":"2026-09283","effective_on":null,"end_page":25577,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/05/11/2026-09283.xml","html_url":"https://www.federalregister.gov/documents/2026/05/11/2026-09283/animal-drug-user-fee-act-stakeholder-consultation-meetings-on-the-animal-drug-user-fee-act","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-09283?publication_date=2026-05-11","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-05-11/2026-09283/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":137,"last_updated":"2026-10-23 04:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-11/pdf/2026-09283.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-09283.pdf?1778244317","publication_date":"2026-05-11","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/05/11/2026-09283.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Summary of Comments Received","document_id":"FDA-2011-N-0656-0037"}],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2011-N-0656","supporting_documents_count":1,"docket_id":"FDA-2011-N-0656","document_id":"FDA-2011-N-0656-1315","regulation_id_number":null,"title":"Animal Drug User Fee Act; Public Meeting","checked_regulationsdotgov_at":"2026-09-09T04:06:42Z"},"regulations_dot_gov_url":"http://www.regulations.gov/commenton/FDA-2011-N-0656-1315","significant":null,"signing_date":null,"start_page":25576,"subtype":null,"title":"Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate","toc_doc":"Animal Drug User Fee Act Reauthorization; Stakeholder Consultation","toc_subject":"Hearings, Meetings, Proceedings, etc.","topics":[],"type":"Notice","volume":91}